Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Flint › NPI 1124085576
Lab

Quest Diagnostics Incorporated Mi

Quest Diagnostics Incorporated Mi was paid $8.64M by Medicaid between Jan 2018 and Mar 2020, across 322 billing codes. Its largest line is 87799, — 8.6% of everything it billed.

33Billing provider infoQUEST DIAGNOSTICS INCORPORATED MI
FLINT, MI 48504
33aNPI1124085576assigned 04/28/2006
33bProvider typeClinical Medical Laboratory
28Total paid$8.64M
24GClaims618,355
24DCodes billed322
24AFirst – last monthJan 2018 – Mar 2020
Compared with peers

Next to other Clinical Medical Laboratory providers in Michigan

Rank by total paid#13 of 108
Median peer was paid$588K
This provider vs. median15×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018469,444$6.86M
2019116,833$1.35M
202032,078$432K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87799 8.6% 12,880 8,016 $748K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7.9% 20,766 17,289 $681K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 7.8% 25,841 25,125 $674K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 7.8% 25,797 25,076 $673K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 7.6% 15,410 12,417 $654K
80061 Lipid panel 3.7% 30,796 30,524 $323K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3.7% 15,562 15,432 $317K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 3.4% 8,057 7,977 $293K
80053 Comprehensive metabolic panel 3.3% 35,266 34,679 $286K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3.1% 14,404 14,044 $267K
87512 3.0% 8,046 7,977 $257K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 2.2% 2,627 2,524 $194K
310 more codes
84443 Thyroid stimulating hormone (TSH) 2.1% 24,875 $183K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.9% 6,271 $165K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1.8% 7,982 $157K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.8% 37,214 $156K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.7% 9,587 $150K
86003 1.4% 3,412 $119K
80081 1.4% 1,956 $118K
80050 General health panel 1.0% 4,801 $89K
83036 Hemoglobin; glycosylated (A1C) 1.0% 18,835 $87K
86480 <1% 1,922 $76K
80074 <1% 2,606 $73K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,371 $65K
87902 <1% 315 $61K
83013 <1% 1,203 $59K
87088 <1% 9,140 $57K
84439 <1% 8,487 $51K
87086 Culture, bacterial; quantitative colony count, urine <1% 12,319 $50K
82607 <1% 5,607 $47K
87522 Neg quan hep c or qual rna <1% 1,479 $46K
84153 <1% 3,483 $42K
86803 <1% 5,271 $40K
87070 <1% 5,772 $40K
86696 <1% 1,874 $34K
82728 <1% 3,455 $33K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 601 $32K
82746 <1% 3,659 $30K
88142 <1% 1,876 $30K
82652 <1% 1,189 $30K
84403 <1% 1,716 $28K
87340 <1% 3,721 $27K
80048 Basic metabolic panel (calcium, ionized) <1% 4,188 $25K
87186 <1% 3,391 $23K
85027 <1% 6,661 $23K
83655 <1% 2,779 $23K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 217 $23K
87536 <1% 507 $21K
84702 <1% 3,914 $21K
87510 <1% 1,227 $20K
87480 <1% 1,228 $20K
87077 <1% 3,072 $20K
87660 <1% 1,174 $19K
84146 <1% 1,442 $19K
81001 <1% 9,491 $19K
86592 <1% 7,305 $17K
83001 <1% 1,528 $17K
82570 <1% 5,918 $16K
83550 <1% 3,402 $16K
86038 <1% 2,494 $15K
87631 <1% 138 $15K
82105 <1% 1,277 $15K
83002 <1% 1,208 $15K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 309 $15K
86235 <1% 425 $14K
84481 <1% 1,202 $13K
86695 <1% 1,625 $13K
82785 <1% 1,186 $13K
84402 <1% 811 $13K
83970 <1% 470 $13K
88141 <1% 928 $13K
84480 <1% 1,423 $13K
82677 <1% 610 $13K
82043 <1% 5,470 $12K
83540 <1% 3,832 $12K
82670 <1% 839 $12K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 50 $11K
87081 <1% 2,765 $11K
86360 <1% 395 $10K
83735 <1% 2,875 $10K
87800 <1% 445 $10K
83021 <1% 879 $9K
86200 <1% 903 $9K
86336 <1% 621 $9K
86706 <1% 1,430 $9K
82950 <1% 2,485 $8K
86704 <1% 1,284 $8K
84436 <1% 1,833 $8K
80348 <1% 1,568 $8K
86708 <1% 1,295 $8K
84550 <1% 3,191 $8K
82627 <1% 425 $8K
83880 <1% 294 $8K
87147 <1% 2,158 $8K
81511 <1% 109 $7K
86008 <1% 123 $7K
86140 <1% 2,221 $7K
86787 <1% 1,042 $7K
86431 <1% 1,823 $7K
80346 <1% 983 $6K
84450 <1% 2,502 $6K
85652 <1% 3,042 $6K
85610 <1% 2,373 $6K
84460 <1% 2,349 $6K
86376 <1% 615 $6K
84144 <1% 458 $6K
86317 <1% 789 $6K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 292 $6K
84479 <1% 1,239 $5K
80362 <1% 856 $5K
82248 <1% 1,452 $5K
80361 <1% 898 $5K
87625 <1% 155 $5K
83525 <1% 541 $5K
82951 <1% 501 $5K
83690 <1% 1,112 $4K
80076 <1% 1,026 $4K
83014 <1% 752 $4K
82274 <1% 311 $4K
83516 <1% 791 $4K
82565 <1% 1,812 $4K
80321 <1% 789 $4K
82947 <1% 2,056 $4K
86812 <1% 160 $4K
88342 <1% 94 $4K
80055 <1% 118 $4K
82784 <1% 316 $4K
86762 <1% 539 $4K
87255 <1% 123 $3K
80164 <1% 495 $3K
84100 <1% 1,516 $3K
80051 <1% 1,016 $3K
86850 <1% 828 $3K
86780 <1% 314 $3K
86800 <1% 288 $3K
80349 <1% 1,089 $3K
80354 <1% 1,342 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 61 $3K
87901 <1% 14 $3K
80353 <1% 813 $3K
82550 <1% 841 $3K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 109 $3K
80356 <1% 710 $3K
80324 <1% 862 $3K
86225 <1% 335 $3K
84520 <1% 1,559 $3K
82107 <1% 67 $3K
80365 <1% 889 $3K
82150 <1% 774 $3K
83615 <1% 800 $3K
85018 <1% 1,539 $3K
87529 <1% 50 $2K
87075 <1% 369 $2K
85730 <1% 831 $2K
80358 <1% 686 $2K
86147 <1% 135 $2K
84703 <1% 626 $2K
83090 <1% 215 $2K
87209 <1% 144 $2K
86141 <1% 213 $2K
84154 <1% 136 $2K
86160 <1% 142 $2K
85014 <1% 1,210 $2K
86162 <1% 114 $2K
87517 <1% 70 $2K
84156 <1% 919 $2K
86039 <1% 219 $2K
82533 <1% 143 $2K
88185 <1% 12 $2K
87205 <1% 520 $2K
87900 <1% 14 $2K
87521 Neg quan hep c or qual rna <1% 68 $2K
86255 <1% 197 $2K
82465 <1% 689 $2K
82977 <1% 478 $2K
86304 <1% 82 $2K
86901 <1% 500 $1K
82672 <1% 107 $1K
36415 Collection of venous blood by venipuncture <1% 27,285 $1K
85660 <1% 570 $1K
81003 <1% 1,542 $1K
87427 <1% 140 $1K
82247 <1% 359 $1K
82024 <1% 35 $1K
80069 <1% 209 $1K
88304 <1% 70 $1K
82310 <1% 539 $1K
83704 <1% 62 $1K
87650 <1% 79 $1K
84270 <1% 321 $1K
86665 <1% 153 $1K
86021 <1% 106 $1K
84165 <1% 174 $1K
87045 <1% 149 $1K
87177 <1% 149 $1K
80178 <1% 236 $1K
84445 <1% 25 $1K
86334 <1% 65 $1K
80159 <1% 109 $1K
87254 <1% 135 $989.92
82040 <1% 431 $976.51
82952 <1% 320 $970.00
87449 <1% 99 $962.69
80177 <1% 88 $950.09
82378 <1% 90 $908.30
84681 <1% 78 $905.96
83921 <1% 73 $904.56
86361 <1% 106 $895.99
82164 <1% 95 $892.64
84425 <1% 126 $883.34
87324 <1% 92 $880.81
86765 <1% 155 $874.37
83010 <1% 148 $852.80
86900 <1% 485 $837.73
80355 <1% 300 $825.08
80373 <1% 757 $807.75
85613 <1% 114 $802.71
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 14 $793.36
83721 <1% 205 $758.68
83498 <1% 60 $744.01
82626 <1% 38 $741.96
86735 <1% 139 $738.00
88312 <1% 12 $710.84
83695 <1% 76 $704.58
82330 <1% 140 $691.91
86709 <1% 136 $675.84
87338 <1% 62 $655.50
84075 <1% 300 $653.26
86705 <1% 108 $647.29
84466 <1% 80 $625.06
83698 <1% 19 $596.13
84140 <1% 44 $578.34
80156 <1% 82 $564.28
81025 <1% 144 $560.60
82140 <1% 96 $549.49
86664 <1% 106 $527.88
86870 <1% 47 $505.83
83520 <1% 388 $493.15
82103 <1% 53 $466.20
88112 <1% 12 $461.79
86301 <1% 29 $457.20
84478 <1% 303 $442.40
80175 <1% 43 $440.77
82175 <1% 27 $437.64
82390 <1% 62 $428.97
85045 <1% 130 $428.55
80366 <1% 191 $425.70
84155 <1% 255 $413.96
86777 <1% 79 $400.68
84630 <1% 59 $389.45
85004 <1% 87 $381.54
80185 <1% 56 $371.08
87076 <1% 56 $370.84
82085 <1% 70 $368.28
85379 <1% 63 $366.51
86593 <1% 114 $363.17
86146 <1% 13 $347.35
82172 <1% 155 $346.80
84207 <1% 41 $313.56
86644 <1% 60 $311.64
87046 <1% 151 $308.89
87140 <1% 43 $305.96
86359 <1% 13 $298.08
86300 <1% 12 $297.18
80360 <1% 599 $297.18
81015 <1% 196 $290.86
86618 <1% 57 $284.64
80165 <1% 28 $281.04
86308 <1% 100 $278.17
88184 <1% 12 $271.60
86645 <1% 51 $267.12
82088 <1% 13 $261.52
85049 <1% 77 $251.86
86702 <1% 31 $242.76
87276 <1% 31 $237.24
87275 <1% 31 $237.24
84132 <1% 153 $234.50
83825 <1% 28 $216.22
84590 <1% 33 $216.00
80202 <1% 25 $215.04
85060 <1% 106 $207.91
86701 <1% 31 $206.12
85048 <1% 96 $199.52
80345 <1% 185 $196.36
82530 <1% 13 $191.40
82525 <1% 27 $172.80
83883 <1% 270 $163.87
85007 <1% 96 $154.88
80372 <1% 157 $148.60
82575 <1% 29 $146.92
85041 <1% 111 $146.90
87329 <1% 12 $144.98
86060 <1% 34 $143.52
86778 <1% 35 $132.72
86774 <1% 27 $117.97
80183 <1% 13 $113.40
86001 <1% 15 $109.06
83718 <1% 35 $108.12
83993 <1% 13 $107.64
89055 <1% 32 $103.34
84295 <1% 81 $93.30
84080 <1% 14 $92.18
80197 <1% 14 $92.16
85597 <1% 14 $79.08
87350 <1% 14 $75.96
87185 <1% 37 $71.55
82435 <1% 68 $69.99
86886 <1% 16 $68.16
84134 <1% 19 $57.22
82374 <1% 33 $47.68
82542 <1% 53 $41.06
80369 <1% 589 $40.33
87101 <1% 18 $38.79
84300 <1% 25 $37.50
89190 <1% 16 $23.60
36416 <1% 26 $22.28
80359 0% 55 $0.00
99001 0% 219 $0.00
80323 0% 14 $0.00
82397 0% 51 $0.00
0001M 0% 50 $0.00
84482 0% 35 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOWLES, CHARLES (VICE PRESIDENT)
Parent organizationQUEST DIAGNOSTICS INCORPORATED
Same official

Other billing entities under BOWLES, CHARLES

Full network →
ProviderLocationPaid
Quest Diagnostics LLCMarlborough, MA$209.74M
Quest Diagnostics of Pennsylvania, INC.Pittsburgh, PA$132.39M
Quest Diagnostics Clinical Laboratories INCSeattle, WA$109.23M
Quest Diagnostics Clinical Laboratories INCPortland, OR$21.85M
Quest Diagnostics of Pennsylvania INC.Buffalo, NY$20.20M
Quest Diagnostics Clinical Laboratories INCCollegeville, PA$12.52M
Solstas Lab Partners Group LLCGreensboro, NC$11.62M
Quest Diagnostics Clinical Laboratories INCTucker, GA$3.66M
Unilab CorporationWest Hills, CA$3.12M
Quest Diagnostics of Pennsylvania INC.Twinsburg, OH$2.56M
Quest Diagnostics Incorporated MDFalls Church, VA$936K
Quest Diagnostics LLCWallingford, CT$706K
Quest Diagnostics of Pennsylvania INC.North Syracuse, NY$492K
Solstas Lab Partners, LLCKnoxville, TN$455K
Quest Diagnostics Clinical Laboratories INCNorristown, PA$319K
Unilab CorporationSan Jose, CA$253K
Unilab CorporationOrange, CA$122K
Quest Diagnostics LLCStratford, CT$103K
Unilab CorporationBakersfield, CA$53K
Quest Diagnostics Clinical Laboratories INCHorsham, PA$48K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.